Fiscal impact
reports (FIRs) are prepared by the Legislative
Finance Committee (LFC) for standing finance committees of the NM Legislature. The
LFC does not assume responsibility for the accuracy of these reports if they
are used for other purposes.
Current FIRs (in HTML & Adobe PDF formats) are available on the
NM Legislative Website (legis.state.nm.us). Adobe PDF versions include all attachments,
whereas HTML versions may not.
Previously issued FIRs and attachments may
also be obtained from the LFC in
SPONSOR |
Sanchez |
DATE TYPED |
|
HB |
|
||
SHORT
TITLE |
Cardiovascular Disease Program |
SB |
252 |
||||
|
ANALYST |
|
|||||
APPROPRIATION
Appropriation
Contained |
Estimated
Additional Impact |
Recurring or
Non-Rec |
Fund Affected |
||
FY04 |
FY05 |
FY04 |
FY05 |
||
|
$70.0 |
|
|
Recurring |
General
Fund |
(Parenthesis
( ) Indicate Expenditure Decreases)
Relates to the Cardiac Arrest Response Act,
Section 24-10C-1, et seq., NMSA 1978, which was enacted in 1999,
regarding the management of cardiac arrest response programs (public access
defibrillation programs).
LFC Files
Responses
Received From
Department
of Health (DOH)
SUMMARY
Synopsis of Bill
Senate Bill 252 appropriates $70,000 from the
General Fund to the Department of Health for fiscal year 2005. The bill creates a Cardiovascular Disease
Program (CVDP) within the Department of Health (DOH). SB252 establishes a CVDP to collect data and
make recommendations on management of heart disease, stroke, and the automated
external defibrillator program.
Significant Issues
According to
2004 statistics released from the American Health Association, cardiovascular
disease (CVD) is the number one killer of people in the
In New Mexico,
according to 2002 Vital Records and Health Statistics Report, diseases of the
heart were the leading cause of death in calendar year 2000 and cerebrovascular disease was the fourth leading cause of
death. Reference is made to “Substantive
Issues” below.
Currently, the
New Mexico Department of Health does not have a formal, dedicated program, for
either cardiovascular or cerebrovascular disease.
SB252
supports initiatives already in place, such as the Stroke Task Force (STF)
developed in response to Senate Joint Memorial 31 (SJM 31), which was introduced
in the 2003 regular session. The STF is
currently being managed through the Injury Prevention and Emergency Medical
Services (IPEMS) Bureau. The STF is
collecting data related to the capacity of
FISCAL IMPLICATIONS
The appropriation of $70.0 contained in this
bill is a recurring expense to the General Fund. Any unexpended or unencumbered
balance remaining at the end of FY 05 shall revert to the General Fund.
The economic effect of cardiovascular
disease on the
ADMINISTRATIVE IMPLICATIONS
SB252
requires personnel a full time staff person to manage the program. The program could be established within a
year and would require some contracts. A
slightly higher appropriation would allow the CVD program to be more successful
in mitigating CVD and mortality related to CVD.
RELATIONSHIP
SB
252 relates to the Cardiac Arrest Response Act, Section 24-10C-1, et seq.,
NMSA 1978, which was enacted in 1999, regarding the management of cardiac
arrest response programs (public access defibrillation programs).
OTHER SUBSTANTIVE ISSUES
Heart disease and stroke, the principal components of cardiovascular
disease, are the first and third leading causes of death in the
Cardiovascular diseases include high
blood pressure, coronary heart disease (heart attack and angina), congestive
heart failure, stroke, and congenital heart defects. Coronary heart disease alone is the single
largest killer of Americans.
According to DOH there is a strong need for a truly comprehensive CVDP in
DOH that would emphasize prevention through education and the reduction of risk
factors. Such a program could capitalize
on the risk factor reduction work already taking place within the Chronic
Disease Prevention and Control Bureau, specifically in the areas of tobacco
control, nutrition, and physical activity.
BD/yr:dm